Cell Line Development Market Projected to Experience a CAGR of 5% from 2022 to 2032, value worth US$ 7.66 Billion | Future Market Insights, Inc. -…

NEWARK, Del, Sept. 14, 2022 (GLOBE NEWSWIRE) -- A recently published study by FMI expects the global demand for cell line development market to increase at a CAGR of 5% during the forecast period between 2022 and 2032, reaching a total of US$ 7.66 Billion in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 6.1%.

The reasons for surge in the market include the increasing demand for regenerative medicine, shifting in focus towards advanced oncology research and rising demand for biologically derived pharmaceuticals. The advancements in culture technologies are expected to significantly impact the growth of the cell line development market through the forecast period. Moreover, the use of monoclonal antibodies as therapeutic agents to treat different types of diseased cells has invoked prospects of growth of the cell line development market.

Stable cell lines are used in various applications, such as drug screening, gene functional studies and biologics production. Increasing demand for monoclonal antibodies and other biological products will continue pushing sales in the cell line development market.

Request a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7566

Key Takeaways from the Market Study

Compared to the existing mammalian expression systems, human cell lines possess the ability to produce proteins analogous to naturally synthesized proteins in the human body. This property is advantageous for the advancement in protein therapeutics, and acts as a driver for the growth of the biopharmaceutical industry. says an analyst at FMI.

Market Competition

Key players in the cell line development market are Thermo Fischer Scientific, Inc., GE Healthcare, Merck KGaA, Lonza (Sartorius Stedim Biotech S.A.), Danaher, Corning Incorporated. WuXi Biologics, Selexis SA and American Type Culture Collection (ATCC).

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-7566

More Insights Available

FMI, in its new offering, presents an unbiased analysis of the global cell line development market, presenting historical analysis from 2017 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of product type (Reagent and Media, Equipment and Accessories and consumables), source type (Mammalian cell line and Non-mammalian cell line), cell lines (Recombinant, Hybridomas, Continuous and Primary cell lines) & region.

About the Healthcare Domain at Future Market Insights

The healthcare domain team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.

Table of Content

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Global Cell Line Development Market Opportunity Analysis

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

Get detailed TOC @ https://www.futuremarketinsights.com/toc/rep-gb-7566

Have a Look at Related Research Reports of Healthcare

Cell Therapy Systems Market Size covering sales outlook, demand forecast & up-to-date key trends

Cell Harvesting Systems Market Demand witnessed substantial growth owing to equipment efficacy and accuracy during stem cells harvest

Cell Culture Incubator Market Share is expected to be valued atUS$ 2,189.7 Millionin 2022, and is projected to reachUS$ 4,347.9 Millionby 2032

Cell Culture Media Bags Market Forecast is projected to increase from a valuation of US$ 1.18 Bn in 2022 to US$ 2.67 by the end of 2030

Lung Cancer Therapeutics Market Forecast: The global lung cancer therapeutics market share is projected to reach US$ 48,725.9 Mn by 2026, exhibiting a CAGR of 13.4% in the forecast period

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5),we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights Inc.Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, USAT: +1-845-579-5705For Sales Enquiries: sales@futuremarketinsights.comBrowse Latest Market Reports: https://www.futuremarketinsights.com/reports

Read the original:
Cell Line Development Market Projected to Experience a CAGR of 5% from 2022 to 2032, value worth US$ 7.66 Billion | Future Market Insights, Inc. -...